Toddlers may sometimes encounter pauses in speech and some levels of disfluencies while speaking, which is a normal aspect of ...

With the hostages now in Israel's custody, one of the main concerns is preventing life-threatening complications such as salt ...

The FDA has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs with a new active substance in ...

By establishing coding and separate payment for certain digital mental health devices, this group from CMS and the FDA hopes ...

In this edition of “Rising High,” The Fly conducted an exclusive interview with Erez Aminov, Chairman & Chief Executive Officer of MIRA ...

A treatment that could potentially slow the progression of amyotrophic lateral sclerosis (ALS) is being studied at the ...

Pheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics ...

Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. Research shows that the drug activates the cannabinoid ...

Neurological conditions are now the leading cause of ill health worldwide, yet remain an enigma. Meet the patients who baffle ...

Robeauté has raised $28m (£23m) to develop its microrobots which enter the brain to diagnose, treat and monitor neurological ...

Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics for the treatment of neurological diseases, announced today it has received clinical trial ...